TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.

Nabil Adra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.